Buy Stocks Easy | About Us
February 23, 2020
Buy Stocks Easy | Online Stocks

KTOV


Buy Kitov Pharma Ltd. Stock (symbol: KTOV) Easy Online

Company Name: Kitov Pharma Ltd.

Symbol: KTOV

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2015

KTOV Current Share Price

Today's KTOV ( Kitov Pharma Ltd. ) opening price: $

Yesterday's KTOV ( Kitov Pharma Ltd. ) closing price: $

Kitov Pharma Ltd. Stock ( symbol: KTOV ) Price Chart since IPO (2015):

12 Months Kitov Pharma Ltd. Stock ( symbol: KTOV ) Price Chart

Popular Questions about Kitov Pharma Ltd. Public Stock ( KTOV )

A: Kitov Pharma Ltd. stock symbol (also called stock or share ticker) is KTOV

A: Kitov Pharma Ltd. IPO (Initial Public Offering) took place on 2015

A: Kitov Pharma Ltd.'s stock (KTOV symbol) price at ther IPO (initial Public Offering) was $

Q: Is KTOV stock worth buying at the moment?

A: The KTOV stock performance since 2019 are rather disappointing. If you had bought 1 share of Kitov Pharma Ltd. stock (symbol: KTOV) at the beginning of 2019, at the opening share price of $1.2700, you would be left with exactly $ - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy Kitov Pharma Ltd. Stock Easy Online

Kitov Pharma Ltd. Stock Ticker Price Chart since IPO:





Kitov Pharma Ltd. Stock Price Yesterday



 


Kitov Pharma Ltd. Stock Price – Last Week




 


Kitov Pharma Ltd. Stock Price – Last Month




 


Kitov Pharma Ltd. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            https://seekingalpha.com/article/4297095-kitov-consensi-commercial-update-supports-value-buy
                            

                                
Kitov: Consensi Commercial Update Supports Value Buy

                                
                                
Kitov Pharma recently updated their Consensi commercial agreement w...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/11/1928635/0/en/Kitov-Pharma-Announces-Amended-Marketing-and-Distribution-Agreement-with-Coeptis-and-Provides-Update-on-the-Upcoming-Launch-of-Consensi-in-the-U-S.html
                            

                                
Kitov Pharma Announces Amended Marketing and Distribution Agreement with Coeptis  and Provides Update on the Upcoming Launch of Consensi™ in the U.S

                                
                                
TEL AVIV, Israel, Oct.  11, 2019  (GLOBE NEWSWIRE) -- Kitov Pharma ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/02/1924062/0/en/Kitov-Pharma-Appoints-Eric-K-Rowinsky-M-D-as-Chairman-of-its-Board.html
                            

                                
Kitov Pharma Appoints Eric K. Rowinsky, M.D.

                                
                                
TEL AVIV, Israel, Oct.  02, 2019  (GLOBE NEWSWIRE) --    Kitov Phar...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/09/1912746/0/en/Kitov-Pharma-Presents-Newly-Released-Data-for-NT-219-in-Reversing-Pancreatic-Cancer-Drug-Resistance.html
                            

                                
Kitov Pharma Presents Newly Released Data for NT-219 in Reversing Pancreatic Cancer Drug Resistance

                                
                                
Kitov Pharma Ltd. (“Kitov”) (NASDAQ/TASE: KTOV), a clinical-stage c...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4289455-tufin-software-technologies-ltd-tufn-ceo-ruvi-kitov-q2-2019-results-earnings-call-transcript
                            

                                
Tufin Software Technologies Ltd. (TUFN) CEO Ruvi Kitov on Q2 2019 Results - Earnings Call Transcript

                                
                                
Tufin Software Technologies Ltd. (TUFN) CEO Ruvi Kitov on Q2 2019 R...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/03/1909983/0/en/Kitov-Pharma-to-Present-at-the-H-C-Wainwright-21st-Annual-Healthcare-Conference.html
                            

                                
Kitov Pharma to Present at the H.C. Wainwright 21st Annual Healthcare Conference

                                
                                
TEL AVIV, Israel, Sept.  03, 2019  (GLOBE NEWSWIRE) -- Kitov Pharma...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/08/29/1908406/0/en/Kitov-Pharma-to-Present-New-Data-on-NT-219-Targeting-Cancer-Drug-Resistance-at-the-AACR-Pancreatic-Cancer-Advances-in-Science-and-Clinical-Care-Conference.html
                            

                                
Kitov Pharma to Present New Data on NT-219 Targeting Cancer Drug Resistance at the AACR Pancreatic Cancer: Advances in Science and Clinical Care Conference

                                
                                
TEL AVIV, Israel, Aug.  29, 2019  (GLOBE NEWSWIRE) --   Kitov Pharm...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4297095-kitov-consensi-commercial-update-supports-value-buy
                            

                                
Kitov: Consensi Commercial Update Supports Value Buy

                                
                                
Kitov Pharma recently updated their Consensi commercial agreement w...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/11/1928635/0/en/Kitov-Pharma-Announces-Amended-Marketing-and-Distribution-Agreement-with-Coeptis-and-Provides-Update-on-the-Upcoming-Launch-of-Consensi-in-the-U-S.html
                            

                                
Kitov Pharma Announces Amended Marketing and Distribution Agreement with Coeptis  and Provides Update on the Upcoming Launch of Consensi™ in the U.S

                                
                                
TEL AVIV, Israel, Oct.  11, 2019  (GLOBE NEWSWIRE) -- Kitov Pharma ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/02/1924062/0/en/Kitov-Pharma-Appoints-Eric-K-Rowinsky-M-D-as-Chairman-of-its-Board.html
                            

                                
Kitov Pharma Appoints Eric K. Rowinsky, M.D.

                                
                                
TEL AVIV, Israel, Oct.  02, 2019  (GLOBE NEWSWIRE) --    Kitov Phar...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/09/1912746/0/en/Kitov-Pharma-Presents-Newly-Released-Data-for-NT-219-in-Reversing-Pancreatic-Cancer-Drug-Resistance.html
                            

                                
Kitov Pharma Presents Newly Released Data for NT-219 in Reversing Pancreatic Cancer Drug Resistance

                                
                                
Kitov Pharma Ltd. (“Kitov”) (NASDAQ/TASE: KTOV), a clinical-stage c...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4289455-tufin-software-technologies-ltd-tufn-ceo-ruvi-kitov-q2-2019-results-earnings-call-transcript
                            

                                
Tufin Software Technologies Ltd. (TUFN) CEO Ruvi Kitov on Q2 2019 Results - Earnings Call Transcript

                                
                                
Tufin Software Technologies Ltd. (TUFN) CEO Ruvi Kitov on Q2 2019 R...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/03/1909983/0/en/Kitov-Pharma-to-Present-at-the-H-C-Wainwright-21st-Annual-Healthcare-Conference.html
                            

                                
Kitov Pharma to Present at the H.C. Wainwright 21st Annual Healthcare Conference

                                
                                
TEL AVIV, Israel, Sept.  03, 2019  (GLOBE NEWSWIRE) -- Kitov Pharma...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/08/29/1908406/0/en/Kitov-Pharma-to-Present-New-Data-on-NT-219-Targeting-Cancer-Drug-Resistance-at-the-AACR-Pancreatic-Cancer-Advances-in-Science-and-Clinical-Care-Conference.html
                            

                                
Kitov Pharma to Present New Data on NT-219 Targeting Cancer Drug Resistance at the AACR Pancreatic Cancer: Advances in Science and Clinical Care Conference

                                
                                
TEL AVIV, Israel, Aug.  29, 2019  (GLOBE NEWSWIRE) --   Kitov Pharm...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.